The CRA wishes to inform members that there is a shortage of Myochrysine (Gold) 25mg/mL and 50 mg/mL injections, Sanofi-Genzyme has confirmed that this shortage is not anticipated to be resolved before September 2019.

Through the CRA Therapeutics Committee, we have worked to ensure a limited supply of 10mg/mL dosage format.  Should you wish to access this medication for your patient(s), you are advised to identify these requirements to your local pharmacist to secure a supply directly from Sanofi-Genzyme (the CRA does not hold nor distribute medications).

We will keep you updated as information becomes available.

Drug Shortages Canada